2019
DOI: 10.1016/j.canlet.2019.08.016
|View full text |Cite
|
Sign up to set email alerts
|

MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 23 publications
(13 citation statements)
references
References 39 publications
0
12
0
Order By: Relevance
“… 37 Various studies have confirmed that COPS5 is highly expressed in ovarian cancer, breast cancer, lung cancer, hepatocellular carcinoma, and osteosarcoma and is associated with tumor progression and poor prognosis. 38 , 39 , 40 , 41 , 42 In this study, we revealed that COPS5 regulated the expression of TRIM24 protein at the post-transcriptional level rather than at the transcriptional level. Through coIP experiments, we confirmed that COPS5 interacted with TRIM24, which was dependent on PVT1 .…”
Section: Discussionmentioning
confidence: 64%
“… 37 Various studies have confirmed that COPS5 is highly expressed in ovarian cancer, breast cancer, lung cancer, hepatocellular carcinoma, and osteosarcoma and is associated with tumor progression and poor prognosis. 38 , 39 , 40 , 41 , 42 In this study, we revealed that COPS5 regulated the expression of TRIM24 protein at the post-transcriptional level rather than at the transcriptional level. Through coIP experiments, we confirmed that COPS5 interacted with TRIM24, which was dependent on PVT1 .…”
Section: Discussionmentioning
confidence: 64%
“…As one of the hub genes of breast cancer prognosis, COPS5, also known as JAB1 or CSN5, was initially identified as c-Jun activation domain-binding protein-1 and is aberrantly overexpressed in various human cancers including breast cancer. Previous studies have demonstrated that COPS5 is involved in controlling cell proliferation, cell cycle, apoptosis, DNA damage response, and drug resistance, which are critical processes in tumorigenesis (26)(27)(28)(29). The TF-target gene network showed that the target genes of COPS5 in breast cancer were CDKN1B and VEGFA (Figure 5C), which were suggested to block G1 growth induced by COPS5 in MDA-MB-453 cells (30), promote breast cancer progress via the HIF1A signaling pathway, and degrade p53 (31).…”
Section: Discussionmentioning
confidence: 99%
“…The high expression of miRNA-17-5p is significantly associated with the progression of various cancers probably through increasing the expression of p53 (Thompson et al, 2016;Duan et al, 2018). However, miRNA-17-5p also reportedly acts as a tumor suppressor in triple-negative breast cancer, which is the breast cancer subtype with the poorest prognosis (Wang et al, 2019). Aberrant expression of miRNA-92a has been reported in various tumors and as such has potential value as a tumor marker or novel target for cancer treatment (Li et al, 2014).…”
Section: Discussionmentioning
confidence: 99%